Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 9, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • SARS-CoV-2
  • Page 13

Tag: SARS-CoV-2

  • BiotechToday
  • World

Dengue, Chikungunya, Zika and COVID-19? A rare mismatch

bioxone October 3, 2020October 2, 2020

Raddur Samaddar, Team bioXone The pandemic is going about its length and breadth, in India, we have 9,43,990 active cases as of 2nd October 2020. The serological activity and also the cross-reactivity of the diseases are a major concern at this moment. A commercial SARS-CoV-2 ELISA test was used for patients diagnosed as Dengue, Zika, […]

Read More
  • BiotechToday
  • World

Catalase: Antioxidant Treatment for COVID-19

bioxone October 2, 2020October 1, 2020 1

-Thota Kanishka Rao, Amity University Kolkata Researchers have discovered that a drug, Catalase, might be the solution to the ongoing coronavirus pandemic. Catalase is a naturally occurring enzyme having the potential as a therapeutic drug treat COVID-19 symptom and suppress the replication of the virus inside the body. Catalase is produced naturally and employed by […]

Read More
  • BiotechToday
  • India
  • World

mRNA-1273: A COVID vaccine for the old?

bioxone October 1, 2020October 1, 2020

Prama Ghosh, Amity University Kolkata Severity and death from Coronavirus disease 2019 (Covid-19) are associated with the older population; testing such vaccine candidates is important to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A phase 1, open-label trial with an escalated dose of messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion […]

Read More
  • BiotechToday
  • India
  • World

Cat Que virus | Another pandemic in India! | ICMR

bioxone September 28, 2020September 28, 2020 4

– Sagnik Nag, Amity University Kolkata The recent pandemic of SARS-CoV-2 was enough to destabilize the global economy and giving a psycho-social upshot throughout the globe that China came up with another lethal cat que virus (CQV). According to a novel scientific study conducted by the Indian Council of Medical Research (ICMR), antibodies for cat […]

Read More
  • BiotechToday
  • World

WASTEWATER – A MEDIUM TO TRACK COVID-19

bioxone September 23, 2020September 23, 2020 1

-Ruchita Karmakar, Amity University Kolkata Researchers extracted the nucleic acid from the sludge solid and used the reverse transcription-quantitative PCR (RT-qPCR) to find the N1 and N2 gene that targets SARs-CoV2. They successfully detected the pathogen in all samples of wastewater. A high-resolution data-set, better than influent and the statistical analysis, emerged from examining wastewater. […]

Read More
  • World

Heparin sulfate: the key to coronavirus infection

bioxone September 18, 2020September 18, 2020

-Arpita Adhikary, Amity University Kolkata It has been observed in the studies that when the SARS-CoV-2 virus infects – Heparin sulfate and ACE2 enter inside the cells. The course of viral entry and successful attachment is quite limpid. Angiotensin-converting enzyme 2 receptors are present on the outer surface of cells that line the lungs. SARS-CoV-2 […]

Read More
  • BiotechToday
  • World

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

bioxone September 16, 2020September 16, 2020

-Binayak Das,Team bioXone A team of scientists has successfully isolated what they believe to be, as being the smallest biological molecule found till date, it being approximately one-tenth the size of an average antibody molecule. They have designed a therapeutic and pre-emptive drug called- Ab8 using it, which they propose will be able to not […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?

bioxone September 10, 2020September 10, 2020

–Biswadeep Sen, Amity University Kolkata Lung Cancer is one of the most malignant tumors, making patients more susceptible to infections than normal individuals. Lung Cancer patients are susceptible to SARS-CoV-2 infection at a significantly higher rate than healthy individuals. Angiotensin-converting enzyme 2, acting as the COVID receptor, and the Transmembrane protease serine 2 acting as […]

Read More

Posts navigation

1 … 9 10 11 12 13

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy